{"id":126835,"date":"2022-01-22T11:37:56","date_gmt":"2022-01-22T04:37:56","guid":{"rendered":"https:\/\/nawacita.co\/?p=126835"},"modified":"2022-01-22T11:37:56","modified_gmt":"2022-01-22T04:37:56","slug":"riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron","status":"publish","type":"post","link":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/","title":{"rendered":"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron"},"content":{"rendered":"<p><strong>Jakarta, Nawacita<\/strong> | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang memadai untuk melawan virus corona varian Omicron.<\/p>\n<p>Melansir Reuters, hal ini terungkap lewat penelitian University of Hong Kong dan Chinese University of Hong Kong.<\/p>\n<p>Dalam penelitian tersebut, para peneliti juga menilai bahwa vaksin mRNA Pfizer-BioNTech lebih efektif karena dosis booster mereka dapat memberikan perlindungan antibodi terhadap Omicron.<\/p>\n<p>Meski begitu, para peneliti tidak menjelaskan seberapa besar perbedaan antibodi yang dihasilkan antara vaksin Sinovac dan juga Pfizer-BioNTech.<\/p>\n<p>Sebelumnya penelitian serupa juga dilakukan di Hong Kong. Penelitian menyebut bahwa dua dosis vaksin Sinovac dan Pfizer sama-sama tidak menghasilkan tingkat serum antibodi yang cukup untuk melawan varian Omicron.<\/p>\n<p>Penelitian tersebut menyarankan kepada masyarakat yang mendapatkan vaksin Sinovac dan Pfizer untuk sesegera mungkin untuk mendapatkan vaksin ketiga atau booster, sambil menunggu ditemukan vaksin yang lebih cocok untuk mengatasi Omicron.<\/p>\n<p>Vaksin Sinovac dan Sinopharm sendiri cukup berbeda dengan vaksin Pfizer atau Moderna. Dua vaksin besutan China ini masih menggunakan teknologi pengembangan virus utuh yang diinaktivasi sementara itu, vaksin Pfizer dan Moderna menggunakan teknologi messenger RNA (mRNA).<\/p>\n<p>cnbc.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jakarta, Nawacita | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang memadai untuk melawan virus corona varian Omicron. Melansir Reuters, hal ini terungkap lewat penelitian University of Hong Kong dan Chinese University of Hong Kong. Dalam penelitian tersebut, para peneliti juga menilai bahwa vaksin mRNA Pfizer-BioNTech lebih [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":126836,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[30300,28669,31636,36783,35401,30063],"class_list":{"0":"post-126835","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nasional","8":"tag-ampuh","9":"tag-covid-19","10":"tag-dikurangi","11":"tag-pfizer","12":"tag-sinovac","13":"tag-vaksin"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron - Nawacita<\/title>\n<meta name=\"description\" content=\"Jakarta, Nawacita | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron - Nawacita\" \/>\n<meta property=\"og:description\" content=\"Jakarta, Nawacita | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/\" \/>\n<meta property=\"og:site_name\" content=\"Nawacita\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-22T04:37:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/01\/Vaksin_Sinovac.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"675\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"redaksi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@nawacit4\" \/>\n<meta name=\"twitter:site\" content=\"@nawacit4\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"redaksi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/\"},\"author\":{\"name\":\"redaksi\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/person\\\/599683af640858fd3b790bc37828ba57\"},\"headline\":\"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron\",\"datePublished\":\"2022-01-22T04:37:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/\"},\"wordCount\":187,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Vaksin_Sinovac.jpg\",\"keywords\":[\"Ampuh\",\"COVID-19\",\"Dikurangi\",\"Pfizer\",\"Sinovac\",\"vaksin\"],\"articleSection\":[\"Nasional\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/\",\"url\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/\",\"name\":\"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron - Nawacita\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Vaksin_Sinovac.jpg\",\"datePublished\":\"2022-01-22T04:37:56+00:00\",\"description\":\"Jakarta, Nawacita | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Vaksin_Sinovac.jpg\",\"contentUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/Vaksin_Sinovac.jpg\",\"width\":675,\"height\":450,\"caption\":\"ilustrasi vaksin sinovac\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/2022\\\/01\\\/22\\\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nawacita.co\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#website\",\"url\":\"https:\\\/\\\/nawacita.co\\\/\",\"name\":\"Nawacita\",\"description\":\"Berita Kementerian, BUMN, Pemerintah dan Politik\",\"publisher\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nawacita.co\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#organization\",\"name\":\"Nawacita\",\"url\":\"https:\\\/\\\/nawacita.co\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Logo-Nawacita-2021.png\",\"contentUrl\":\"https:\\\/\\\/nawacita.co\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/Logo-Nawacita-2021.png\",\"width\":1676,\"height\":422,\"caption\":\"Nawacita\"},\"image\":{\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/nawacitaco-1763136813898723\\\/?ref=aymt_homepage_panel\",\"https:\\\/\\\/x.com\\\/nawacit4\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nawacita.co\\\/#\\\/schema\\\/person\\\/599683af640858fd3b790bc37828ba57\",\"name\":\"redaksi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g\",\"caption\":\"redaksi\"},\"sameAs\":[\"nawacitaportal\",\"https:\\\/\\\/x.com\\\/nawacit4\"],\"url\":\"https:\\\/\\\/nawacita.co\\\/index.php\\\/author\\\/redaksi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron - Nawacita","description":"Jakarta, Nawacita | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/","og_locale":"en_US","og_type":"article","og_title":"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron - Nawacita","og_description":"Jakarta, Nawacita | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang","og_url":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/","og_site_name":"Nawacita","article_publisher":"https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel","article_published_time":"2022-01-22T04:37:56+00:00","og_image":[{"width":675,"height":450,"url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/01\/Vaksin_Sinovac.jpg","type":"image\/jpeg"}],"author":"redaksi","twitter_card":"summary_large_image","twitter_creator":"@nawacit4","twitter_site":"@nawacit4","twitter_misc":{"Written by":"redaksi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#article","isPartOf":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/"},"author":{"name":"redaksi","@id":"https:\/\/nawacita.co\/#\/schema\/person\/599683af640858fd3b790bc37828ba57"},"headline":"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron","datePublished":"2022-01-22T04:37:56+00:00","mainEntityOfPage":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/"},"wordCount":187,"commentCount":0,"publisher":{"@id":"https:\/\/nawacita.co\/#organization"},"image":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#primaryimage"},"thumbnailUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/01\/Vaksin_Sinovac.jpg","keywords":["Ampuh","COVID-19","Dikurangi","Pfizer","Sinovac","vaksin"],"articleSection":["Nasional"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/","url":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/","name":"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron - Nawacita","isPartOf":{"@id":"https:\/\/nawacita.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#primaryimage"},"image":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#primaryimage"},"thumbnailUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/01\/Vaksin_Sinovac.jpg","datePublished":"2022-01-22T04:37:56+00:00","description":"Jakarta, Nawacita | Riset terbaru menunjukkan bahwa tiga dosis vaksin Covid-19 buatan Sinovac China gagal menghasilkan tingkat antibodi yang","breadcrumb":{"@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#primaryimage","url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/01\/Vaksin_Sinovac.jpg","contentUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/01\/Vaksin_Sinovac.jpg","width":675,"height":450,"caption":"ilustrasi vaksin sinovac"},{"@type":"BreadcrumbList","@id":"https:\/\/nawacita.co\/index.php\/2022\/01\/22\/riset-sebut-vaksin-sinovac-kurang-ampuh-lawan-omicron\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nawacita.co\/"},{"@type":"ListItem","position":2,"name":"Riset Sebut Vaksin Sinovac Kurang Ampuh Lawan Omicron"}]},{"@type":"WebSite","@id":"https:\/\/nawacita.co\/#website","url":"https:\/\/nawacita.co\/","name":"Nawacita","description":"Berita Kementerian, BUMN, Pemerintah dan Politik","publisher":{"@id":"https:\/\/nawacita.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nawacita.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nawacita.co\/#organization","name":"Nawacita","url":"https:\/\/nawacita.co\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nawacita.co\/#\/schema\/logo\/image\/","url":"https:\/\/nawacita.co\/wp-content\/uploads\/2021\/10\/Logo-Nawacita-2021.png","contentUrl":"https:\/\/nawacita.co\/wp-content\/uploads\/2021\/10\/Logo-Nawacita-2021.png","width":1676,"height":422,"caption":"Nawacita"},"image":{"@id":"https:\/\/nawacita.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/nawacitaco-1763136813898723\/?ref=aymt_homepage_panel","https:\/\/x.com\/nawacit4"]},{"@type":"Person","@id":"https:\/\/nawacita.co\/#\/schema\/person\/599683af640858fd3b790bc37828ba57","name":"redaksi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a3ea3038dabe75a981e9a69b300b8272c74e0729c55e2f30478cde7add6c42f6?s=96&d=mm&r=g","caption":"redaksi"},"sameAs":["nawacitaportal","https:\/\/x.com\/nawacit4"],"url":"https:\/\/nawacita.co\/index.php\/author\/redaksi\/"}]}},"jetpack_featured_media_url":"https:\/\/nawacita.co\/wp-content\/uploads\/2022\/01\/Vaksin_Sinovac.jpg","_links":{"self":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts\/126835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/comments?post=126835"}],"version-history":[{"count":0,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/posts\/126835\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/media\/126836"}],"wp:attachment":[{"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/media?parent=126835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/categories?post=126835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nawacita.co\/index.php\/wp-json\/wp\/v2\/tags?post=126835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}